Benjamin Levy III, MD, a gastroenterologist at University of Chicago Medicine, told Becker’s that it is important to continue providing screening colonoscopies for Medicare patients, especially as colon cancer rates continue to rise.
Colon cancer is among the most common types of cancer diagnosed in both men and women, and cancer rates for those under 50 have risen 13% since 2000.
Dr. Benjamin Levy: UChicago Medicine accepts traditional Medicare and is contracted as an in-network provider with select Medicare Advantage plans. I can’t speak on behalf of the health system, but as a gastroenterologist, I am especially thankful that Medicare covers screening colonoscopies so that we can prevent colorectal cancer by removing polyps. In addition, Medicare also covers diagnostic colonoscopies performed after noninvasive stool-based screening tests such as fecal immunochemical or Cologuard testing.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
